Comparative Intraocular Penetration of 4 Fluoroquinolones After Topical Instillation

被引:23
作者
Chung, Jae Lim [1 ]
Lim, Eun Hye [1 ]
Song, Sang Wroul [1 ]
Kim, Byung Yeop [1 ]
Lee, Joon H. [1 ]
Mah, Francis S. [2 ,3 ]
Seo, Kyoung Yul [4 ]
机构
[1] Konyang Univ, Coll Med, Kims Eye Hosp, Myung Gok Eye Res Inst,Dept Ophthalmol, Seoul, South Korea
[2] Scripps Res Inst, Div Ophthalmol, La Jolla, CA USA
[3] Univ Pittsburgh, Charles T Campbell Ophthalm Microbiol Lab, Pittsburgh, PA USA
[4] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul 120752, South Korea
关键词
ocular penetration; fluoroquinolone; quinolone; pharmacokinetics; eye; OPHTHALMIC SOLUTION; AQUEOUS-HUMOR; IN-VITRO; RABBIT MODEL; MOXIFLOXACIN; ANTIBIOTICS; PHARMACOKINETICS; LEVOFLOXACIN; 0.5-PERCENT; BESIFLOXACIN;
D O I
10.1097/ICO.0b013e31828d6d9e
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the intraocular penetration of 4 fluoroquinolone eye drops after topical instillation into rabbit eyes. Methods: The tested drugs were levofloxacin 1.5% (LVFX), gatifloxacin 0.3%, moxifloxacin 0.5% (MFLX), and besifloxacin 0.6% (BFLX). Forty-eight New Zealand white rabbits were randomly assigned into 2 groups. For group 1 (40 rabbits, 80 eyes), single instillation was performed, and tissue samples were acquired after 0.5, 1, 2, 4, and 6 hours. For group 2 (8 rabbits, 16 eyes), repeated instillation was performed (4 times, every 15 minutes), and tissues were acquired 1 hour after the fourth instillation. The drug concentrations in ocular tissues (cornea, aqueous, conjunctiva, and trisected vitreous) were analyzed with high-performance liquid chromatography. Results: The AUC(0-6 h) (area under the curve, in microgram. hour/gram) in group 1 and the mean concentration (in micrograms/gram) in group 2 for LVFX, gatifloxacin 0.3%, MFLX, and BFLX, respectively, were 22.97, 6.44, 13.54, and 3.29 and 22.60, 6.99, 13.69, and 1.91 in cornea; 5.66, 1.43, 3.38, and 0.42 and 5.52, 1.29, 2.47, and 0.19 in aqueous humor; 2.33, 0.91, 2.17, and 9.83 and 4.51, 0.78, 1.48, and 2.09 in bulbar conjunctiva; 0.243, 0.051, 0.134, and 0.018 and 0.182, 0.055, 0.122, and 0.015 in anterior vitreous; none of the drugs achieved enough concentration in equatorial and posterior vitreous. Repeated instillation resulted in approximately 2.1 times greater penetration than single instillation. Conclusions: LVFX and MFLX demonstrated good intraocular penetration particularly in cornea, aqueous humor, and anterior vitreous, and they may be considered the penetrative fluoroquinolones. BFLX showed high concentration in bulbar conjunctiva and may be considered the retentive fluoroquinolone.
引用
收藏
页码:1046 / 1051
页数:6
相关论文
共 27 条
  • [1] An adaptable HPLC method for the analysis of frequently used antibiotics in ocular samples
    Davis, Lindsay T.
    Kumar, Neeru
    Nijm, Lisa M.
    Ulanski, Lawrence J., II
    Tu, Elmer Y.
    Fiscella, Richard G.
    Peterson, Randal J.
    Glickman, Randolph D.
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2010, 878 (26): : 2421 - 2426
  • [2] Review of pharmacokinetics and pharmacodynamics of antimicrobial agents
    Estes, L
    [J]. MAYO CLINIC PROCEEDINGS, 1998, 73 (11) : 1114 - 1122
  • [3] The effect of the corneal epithelium on the intraocular penetration of fluoroquinolone ophthalmic solution
    Fukuda, M
    Inoue, A
    Sasaki, K
    Takahashi, N
    [J]. JAPANESE JOURNAL OF OPHTHALMOLOGY, 2004, 48 (02) : 93 - 96
  • [4] Vitreous and Aqueous Penetration of Orally and Topically Administered Moxifloxacin
    Fukuda, Masamichi
    Shibata, Naoko
    Osada, Hiromi
    Yamashiro, Yoko
    Sasaki, Hiroshi
    [J]. OPHTHALMIC RESEARCH, 2011, 46 (03) : 113 - 117
  • [5] Besifloxacin, a Novel Fluoroquinolone, Has Broad-Spectrum In Vitro Activity against Aerobic and Anaerobic Bacteria
    Haas, Wolfgang
    Pillar, Chris M.
    Zurenko, Gary E.
    Lee, Jacqueline C.
    Brunner, Lynne S.
    Morris, Timothy W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) : 3552 - 3560
  • [6] Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous
    Hariprasad, SM
    Blinder, KJ
    Shah, GK
    Apte, RS
    Rosenblatt, B
    Holekamp, NM
    Thomas, MA
    Mieler, WF
    Chi, JD
    Prince, RA
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (01) : 39 - 44
  • [7] Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients
    Kim, DH
    Stark, WJ
    O'Brien, TP
    Dick, JD
    [J]. OPHTHALMOLOGY, 2005, 112 (11) : 1992 - 1996
  • [8] Aqueous humor penetration of fourth-generation fluoroquinolone ophthalmic solutions given by multiple administration in a rabbit model
    Kobayakawa, Shinichiro
    Ooki, Kohtarou
    Tsuji, Akiyoshi
    Tochikubo, Tetsuo
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2009, 15 (04) : 209 - 213
  • [9] Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models
    Kowalski, Regis P.
    Romanowski, Eric G.
    Mah, Francis S.
    Shanks, Robert M. Q.
    Gordon, Y. J.
    [J]. ACTA OPHTHALMOLOGICA, 2010, 88 (04) : e120 - e125
  • [10] An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data
    Kowalski, RP
    Yates, KA
    Romanowski, EG
    Karenchak, LM
    Mah, FS
    Gordon, YJ
    [J]. OPHTHALMOLOGY, 2005, 112 (11) : 1987 - 1991